H-RAS 81 polymorphism is significantly associated with aneuploidy in follicular tumors of the thyroid

Oncogene

Volumn 25, Issue 33, 2006, Pages 4620-4627

  Castro, P ^a   Soares, P ^a,b   Gusmao L ^a   Seruca, R ^a,b   Sobrinho Simoes M ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b Faculty of Engineering of Porto   (Portugal)

Author keywords

Aneuploidy; H RAS polymorphism; H RAS splicing; RAS mutations

Indexed keywords

CYTOSINE; ISOPROTEIN; MESSENGER RNA; PROTEIN P19; PROTEIN P21; RAS PROTEIN; THYMINE;

ANEUPLOIDY; ARTICLE; BLOOD DONOR; CANCER CONTROL; CELL CYCLE S PHASE; CELL FRACTIONATION; CELL TRANSFORMATION; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; GOITER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NODULAR GOITER; ONCOGENE RAS; ONCOGENE RAS 81; PLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RNA SPLICING; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID TUMOR; TUMOR CELL CULTURE;

ADENOCARCINOMA, FOLLICULAR; ALLELES; ALTERNATIVE SPLICING; ANEUPLOIDY; GENES, NEOPLASM; GENES, RAS; HUMANS; MODELS, GENETIC; MUTATION; PLOIDIES; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RAS PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID NEOPLASMS;

EID: 33746789351     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209491     Document Type: Article

References (46)

1. Bos JL. (1989). Cancer Res 49: 4682-4689.
2. Castro P, Eknaes M, Teixeira MR, Danielsen HE, Soares P, Lothe RA et al. (2005). J Pathol 206: 305-311.
3. Castro P, Sansonetty F, Soares P, Dias A, Sobrinho-Simoes M. (2001). Virchows Arch 438: 336-342.
4. Codony C, Guil S, Caudevilla C, Serra D, Asins G, Graessmann A et al. (2001). Oncogene 20: 3683-3694.
5. Cohen JB, Broz SD, Levinson AD. (1989). Cell 58: 461-472.
6. Cohen JB, Broz SD, Levinson AD. (1993). Mol Cell Biol 13: 2666-2676.
7. Coleman ML, Marshall CJ, Olson MF. (2004). Nat Rev Mol Cell Biol 5: 355-366.
8. Cusick EL, Ewen SW, Krukowski ZH, Matheson NA. (1991). Br J Surg 78: 94-96.
9. Deitch AD, Law H, White RD. (1982). J Histochem Cytochem 30: 967-972.
10. DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) (2004). Pathology and Genetics of Tumours of Endocrine Organs. IARC Press: USA.
11. Denko N, Stringer J, Wani M, Stambrook P. (1995). Somat Cell Mol Genet 21: 241-253.
12. Denko NC, Giaccia AJ, Stringer JR, Stambrook PJ. (1994). Proc Natl Acad Sci USA 91: 5124-5128.
13. Esapa CT, Johnson SJ, Kendall-Taylor P, Lennard TW, Harris PE. (1999). Clin Endocrinol (Oxford) 50: 529-535.
14. Fagin JA. (2002). Mol Endocrinol 16: 903-911.
15. Feramisco JR, Gross M, Kamata T, Rosenberg M, Sweet RW. (1984). Cell 38: 109-117.
16. Giaretti W, Molinu S, Ceccarelli J, Prevosto C. (2004). Cell Oncol 26: 301-305.
17. Giaretti W, Pujic N, Rapallo A, Nigro S, Di Vinci A, Geido E et al. (1995). Gastroenterology 108: 1040-1047.
18. Giaretti W, Rapallo A, Geido E, Sciutto A, Merlo F, Risio M et al. (1998). Am J Pathol 153: 1201-1209.
19. Guil S, de La Iglesia N, Fernandez-Larrea J, Cifuentes D, Ferrer JC, Guinovart JJ et al. (2003a). Cancer Res 63: 5178-5187.
20. Guil S, Gattoni R, Carrascal M, Abian J, Stevenin J, Bach-Elias M. (2003b). Mol Cell Biol 23: 2927-2941.
21. Hara H, Fulton N, Yashiro T, Ito K, DeGroot LJ, Kaplan EL. (1994). Surgery 116: 1010-1016.
22. Hostetter AL, Hrafnkelsson J, Wingren SOW, Enestrom S, Nordenskjöld B. (1988). Am J Clin Pathol 89: 760-763.
23. Huang MY, Cohen JB. (1997). Oncol Res 9: 611-621.
24. Illmer T, Thiede C, Fredersdorf A, Stadler S, Neubauer A, Ehninger G et al. (2005). Clin Cancer Res 11: 3217-3224.
25. Joensuu H, Klemi PJ. (1988). Am J Clin Pathol 89: 35-40.
26. Johannessen JV, Sobrinho-Simões M, Tangen KO. (1982). Am J Clin Pathol 77: 20-25.
27. Johne A, Roots I, Brockmoller J. (2003). Epidemiol Biomarkers Prev 12: 68-70.
28. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA. (2003). Cancer Res 63: 1454-1457.
29. Krontiris TG, Devlin B, Karp DD, Robert NJ, Risch N. (1993). N Engl J Med 329: 517-523.
30. Liwo A, Gibson KD, Scheraga HA, Brandt-Rauf PW, Monaco R, Pincus MR. (1994). J Protein Chem 13: 237-251.
31. Mammas IN, Zafiropoulos A, Koumantakis E, Sifakis S, Spandidos DA. (2004). Gynecol Oncol 92: 941-948.
32. Mascaux C, Iannino N, Martin B, Paesmans M, Berghmans T, Dusart M et al. (2005). Br J Cancer 92: 131-139.
33. Monaco R, Chen JM, Chung D, Brandt-Rauf P, Pincus MR. (1995). J Protein Chem 14: 457-466.
34. Mulcahy LS, Smith MR, Stacey DW. (1985). Nature 313: 241-243.
35. Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn II GW, Tallini G et al. (2003). J Clin Endocrinol Metab 88: 2318-2326.
36. Noonan T, Brown N, Dudycz L, Wright G. (1991). J Med Chem 34: 1302-1307.
37. Pastinen T, Hudson TJ. (2004). Science 306: 647-650.
38. Pulciani S, Santos E, Long LK, Sorrentino V, Barbacid M. (1985). Mol Cell Biol 5: 2836-2841.
39. Rosai J, Carcangiu ML, DeLellis RA. (1993). Tumors of the Thyroid Gland (Atlas of tumor pathology, 3rd series, fascicle 5) Armed forces Isntitute of Pathology: Washington, DC.
40. Saavedra HI, Knauf JA, Shirokawa JM, Wang J, Ouyang B, Elisei R et al. (2000). Oncogene 19: 3948-3954.
41. Schelfhout LJ, Cornelisse CJ, Goslings BM, Hamming JF, Kuipers-Dijkshoorn NJ, van de Velde CJ et al. (1990). Int J Cancer 45: 16-20.
42. Schneider S, Roessli D, Excoffier L. (2000). Arlequin: a software for population genetics data analysis. Genetics and Biometry Lab, Department of Anthropology, University of Geneva.
43. Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A et al. (2003). Oncogene 22: 4578-4580.
44. Sugg SL, Ezzat S, Zheng L, Freeman JL, Rosen IB, Asa SL. (1999). Surgery 125: 46-52.
45. Tabin CJ, Bradley SM, Bargmann CI, Weinberg RA, Papageorge AG, Scolnick EM et al. (1982). Nature 300: 143-149.
46. Wang B, Soule HD, Miller FR. (1997). Anticancer Res 17: 4387-4394.